Testing a new drug plus radiation for brain metastases
Part of Cancer clinical trials.
This trial tests a new drug (ascorbate-meglumine) given before a single session of high-precision radiation (SRS) for people with newly diagnosed brain metastases. The goal is to see if the drug can make the radiation more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of brain metastases (cancer that spread to the brain) from another cancer.
- You have 1 to 3 brain tumors that are small (under 2.5 cm) and have not been treated before.
- Your treatment plan is to have a single session of high-precision radiation (SRS) to the brain.
- You are at least 18 years old and expected to live at least 3 more months.
- You cannot have a brain tumor in certain sensitive areas (like the brainstem) or near the optic nerve.
- You must not have certain conditions like G6PD deficiency, kidney stones, iron overload, or be on specific medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
This trial tests giving focused radiation (radiosurgery) before surgery for certain resectable brain metastases. It may help shrink or control tumors in the brain before they are surgically removed.
This trial tests a new way to deliver radiation to brain metastases from non-small cell lung cancer, using MRI scans to guide the treatment and reduce the area exposed. The goal is to see if this approach is safe and effective while possibly lowering side effects.
This study looks at how well a new anti-tumor drug works when given along with radiation therapy for people whose advanced breast cancer has spread to the brain. It may help the radiation work better and control the cancer longer.
This Phase 1 study tests how to safely give focused radiation (SRS) at different doses to people with brain metastases. It aims to find a dose level that works well while limiting side effects.
This trial compares two stereotactic radiation strategies for patients who have intact (not previously radiated) brain metastases that are limited in size. It aims to see which approach works best in controlling the cancer while reducing side effects.
Hear when a new Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.